Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Total Liabilities: 2022-2023

Historic Total Liabilities for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $62.2 million.

  • Therapeutics' Total Liabilities rose 238.24% to $62.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $62.2 million, marking a year-over-year increase of 238.24%. This contributed to the annual value of $25.6 million for FY2022, which is N/A change from last year.
  • According to the latest figures from Q3 2023, Therapeutics' Total Liabilities is $62.2 million, which was down 1.10% from $62.9 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Total Liabilities ranged from a high of $62.9 million in Q2 2023 and a low of $15.3 million during Q2 2022.
  • For the 2-year period, Therapeutics' Total Liabilities averaged around $33.6 million, with its median value being $25.6 million (2022).
  • Data for Therapeutics' Total Liabilities shows a peak YoY surged of 310.29% (in 2023) over the last 5 years.
  • Therapeutics' Total Liabilities (Quarterly) stood at $25.6 million in 2022, then skyrocketed by 238.24% to $62.2 million in 2023.
  • Its last three reported values are $62.2 million in Q3 2023, $62.9 million for Q2 2023, and $33.8 million during Q1 2023.